This JAMA Patient Page describes the indications for use of medications to reduce breast cancer risk and the benefits and risks of the 2 major drug classes, SERMs (tamoxifen, raloxifene) and aromatase inhibitors (anastrozole, exemestane).
This Viewpoint explores the widespread effects cuts to Medicaid funding could have on the US medical system, including limitations on states, hospitals, and physicians, as…
This study uses data from the California Comprehensive Death Files to examine how California life expectancy varied by year, income, race and ethnicity, and contributing…
The state’s life expectancy was lower in 2024 than in 2019, according to an analysis, but primarily as a result of causes of death other…
This narrative review discusses the uncertainties, challenges, and specific areas of novel research in the growing field of inflammation and adult psychiatric disorders.
This cluster randomized trial examines whether a more intensive implementation strategy resulted in greater use of a mobile app targeting multilevel barriers to colorectal cancer…
This cross-sectional study assesses the reliability of the Ichthyosis Scoring System in individuals with Fitzpatrick IV to VI skin types.
This cohort study analyzes cardiovascular health data from participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study to determine whether Life’s Essential…
This multicenter randomized clinical trial conducted at 4 pediatric Canadian emergency departments determines whether pain in children with toddler’s fractures treated with a removable boot…
This randomized clinical trial compares the use of diversified segmental defocus optimization lenses with and without atropine, 0.01%, for the prevention of myopia.
This case series study examines the use and outcomes of total neoadjuvant therapy in routine practice for patients with rectal cancer.
